HPTN Publications

Incidence Assay Critical Path Working Group . More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med. 2011, 8: e1001045

Irvin R, Gamble T, Malone J, Wang Z, Wilson E, Hughes JP, Farley J, Mayer KH, Del Rio C, Batey DS, Cummings V, Remien RH, Beyrer C, Thio CL . HIV Prevention Trials Network 078: High Prevalence of Hepatitis C Virus Antibodies Among Urban US Men Who Have Sex With Men, Independent of Human Immunodeficiency Virus Status. Clin Infect Dis. 2021, 73: e2205-e2210

Irvin R, Gamble T, Malone J, Wang Z, Wilson E, Hughes JP, Farley J, Mayer KH, Del Rio C, Batey DS, Cummings V, Remien RH, Beyrer C, Thio CL . HPTN 078: High Prevalence of HCV Antibodies among Urban U.S. Men Who Have Sex with Men (Msm) Independent of HIV Status. Clin Infect Dis.

Irvin R, Vallabhaneni S, Scott H, Williams JK, Wilton L, Li X, Buchbinder S; HPTN 061, Buchbinder S, HPTN 061 . Examining Levels of Risk Behaviors among Black Men Who Have Sex with Men (MSM) and the Association with HIV Acquisition. PLoS One. 2015, 10: e0118281

Irvin R, Wilton L, Scott H, Beauchamp G, Wang L, Betancourt J, Lubensky M, Wallace J, Buchbinder S . A Study of Perceived Racial Discrimination in Black Men Who Have Sex with Men (MSM) and Its Association with Healthcare Utilization and HIV Testing. AIDS Behav. 2014, 18: 1272-8

Iwuji C, Newell ML . Towards control of the global HIV epidemic: Addressing the middle-90 challenge in the UNAIDS 90-90-90 target. PLoS Med. 2017, 14: e1002293

Jackson B, Mmiro F, HIVNET 012 Study Team . HIVNET 012 and Petra (authors' reply). Lancet. 2004, 363: 244

Jackson JB, Barnett S, Piwowar-Manning E, Apuzzo L, Raines, C, Hendrix C, Hamzeh F, Gallant J . A Phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk. AIDS. 2003, 17: 547-53